- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02866591
Interest of Self-compression Technique on Tolerance of Mammography (ITACTs)
Mammography is used for screening, diagnosis, therapeutic evaluation and monitoring of local cancer breast.
It is sometimes poorly tolerated by some patients who complain of an uncomfortable examination or pain.
Breast compression by the manipulator aims to reduce the thickness of the breast during mammography; This act is an important factor of pain or discomfort felt by the patient. But, it is also an image quality factor.
This study aimed to compare self-breast compression by the patient to the compression standard technique carried out by the manipulator.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33000
- Institut Bergonie
-
Caen, France, 14076
- Centre Francois Baclesse
-
Nancy, France, 54000
- Cabinet de Radiologie
-
Nancy, France, 54000
- Polyclinique Majorelle
-
Paris, France, 75248
- Institut Curie
-
Vandoeuvre-les-Nancy, France, 54519
- Institut de Cancérologie de Lorraine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients ≥ 18 years and ≤ 75 years of age
- ECOG performance <2
- Mammography planned as part of a breast cancer screening or a monitoring following treatment of a breast lesion
- Ability to provide written informed consent
- Patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study.
Exclusion Criteria:
- Eastern Cooperative Oncology Group performance status ≥ 2
- Treatment for benign lesion with surgery for less than 3 years
- Treatment for cancer with surgery and / or radiotherapy for less than 3 years
- Biopsy for less than 1 year
- Breast prosthesis
- Mastectomy
- Assessment motivated by a clinical breast abnormality
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm A
Patients have a mammography performed by themselves according to auto-compression procedure.
The radiologist leads the compression at a minimum threshold of 40 Newton, then leaves the control of the compression to the patient.
The radiologist treats only the positioning of the breast on the sensor.
|
|
|
Active Comparator: Arm B
Patients have a mammography performed by the radiologist according to standard procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of two breast compression techniques (auto-compression versus standard procedure) in mammography
Time Frame: 1 day
|
The comparison will be evaluated by the thickness (mm) of breast compressed
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall tolerance of mammography
Time Frame: 1 day
|
The overall tolerance of mammography will be assessed by the patient after 4 shots.
The pain felt by the patient will be assessed using a visual analog scale.
|
1 day
|
|
Breast compression force
Time Frame: 1 day
|
Value measured on compressive force console (Newtons)
|
1 day
|
|
Thickness / compressing force ratio
Time Frame: 1 day
|
1 day
|
|
|
Image quality
Time Frame: 1 day
|
The image quality will be assessed by the radiologist with a quotation of motion blurring on a 4-point scale
|
1 day
|
|
Overall assessment of the manipulator
Time Frame: 1 day
|
The appreciation of the manipulator will be assessed using a 4-point scale
|
1 day
|
|
Overall assessment of self-satisfaction of the patient at the end of the examination
Time Frame: 1 day
|
The measurement of patient satisfaction will be evaluated using a self-administered Norwegian questionnaire (MammoGraphy Questionnaire)
|
1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: HENROT Philippe, MD, Institut de Cancérologie de Lorraine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2012-A00248-35
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
Clinical Trials on mammography according to an auto-compression procedure
-
Cancer Prevention and Research Institute, ItalyMinistry of Health, ItalyUnknown
-
St. Olavs HospitalNorwegian Air Ambulance FoundationActive, not recruitingCardiac ArrestNorway, Italy, Denmark
-
Karolinska University HospitalRalf Segersvärd; Afshin Noorani; John BlombergTerminatedThe Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection.50 % Reduction of Delayed Gastric EmptyingSweden
-
Medtronic BRCVitatron GmbHCompletedSick Sinus SyndromeGermany
-
Uppsala UniversityRecruiting
-
Michel BouvierClinique Charcot; Polyclinique du BeaujolaisCompletedOral Allergic Syndrome | Allergic Reaction Caused by Food (Disorder)
-
Capital Medical UniversityNot yet recruiting
-
Karaman Training and Research HospitalCompletedChild Behavior | Anxiety StateTurkey
-
Basque Health ServiceCarlos III Health Institute; Preventive Services and Health Promotion Research... and other collaboratorsUnknown
-
U-Systems, Inc.Completed